Susquehanna International Group
CLLS

Susquehanna International Group’s Cellectis CLLS Stock Holding History

Susquehanna International Group’s Portfolio CLLS Stock Details CLLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-16,800
Closed -$31.4K – 12091
2024
Q2 		$31.4K Sell
16,800
-14,100
-46% -$37K ﹤0.01% 11550
2024
Q1 		$81.9K Buy
+30,900
New +$85.5K ﹤0.01% 11327
2022
Q3 		– Sell
-10,100
Closed -$29K – 13252
2022
Q2 		$29K Sell
10,100
-4,300
-30% -$15.1K ﹤0.01% 12233
2022
Q1 		$65K Sell
14,400
-2,700
-16% -$14.9K ﹤0.01% 12169
2021
Q4 		$139K Sell
17,100
-2,900
-15% -$28.5K ﹤0.01% 11877
2021
Q3 		$252K Sell
20,000
-12,100
-38% -$168K ﹤0.01% 10992
2021
Q2 		$497K Sell
32,100
-12,400
-28% -$208K ﹤0.01% 9613
2021
Q1 		$899K Buy
44,500
+17,500
+65% +$433K ﹤0.01% 8012
2020
Q4 		$731K Buy
+27,000
New +$606K ﹤0.01% 7422
2019
Q3 		– Sell
-42,600
Closed -$665K – 10209
2019
Q2 		$665K Sell
42,600
-11,700
-22% -$209K ﹤0.01% 6638
2019
Q1 		$996K Buy
+54,300
New +$962K ﹤0.01% 5051
2018
Q4 		– Sell
-74,200
Closed -$2.09M – 9022
2018
Q3 		$2.09M Buy
74,200
+11,900
+19% +$342K ﹤0.01% 3911
2018
Q2 		$1.76M Buy
62,300
+25,300
+68% +$753K ﹤0.01% 4232
2018
Q1 		$1.17M Buy
37,000
+8,400
+29% +$265K ﹤0.01% 4936
2017
Q4 		$834K Sell
28,600
-29,000
-50% -$790K ﹤0.01% 5603
2017
Q3 		$1.64M Buy
57,600
+32,000
+125% +$828K ﹤0.01% 4283
2017
Q2 		$661K Sell
25,600
-37,900
-60% -$905K ﹤0.01% 6098
2017
Q1 		$1.52M Buy
63,500
+18,400
+41% +$387K ﹤0.01% 4239
2016
Q4 		$764K Buy
+45,100
New +$833K ﹤0.01% 6089

Other funds holding CLLS

BGI
B Group Inc Dallas, Texas $135M AUM 80% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Susquehanna International Group's CLLS Position: Q1 2026 in Review

Susquehanna International Group increased its Cellectis (CLLS) stake by 26% in Q1 2026, buying an estimated $51.8K and bringing the position to 65,942 shares worth $209K. The position accounts for ﹤0.01% of the portfolio, ranked #11615.

Susquehanna International Group first reported a position in CLLS in Q3 2016 and has held it in 25 quarters since. The position peaked at $1.23M in Q4 2020. 32 funds tracked by Wall St. Rank hold CLLS as of Q1 2026.

  • Susquehanna International Group held 65,942 shares of Cellectis worth $209K as of Q1 2026.
  • Susquehanna International Group bought 13,519 Cellectis shares in Q1 2026, an estimated $51.8K.
  • Cellectis made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #11615 holding.
  • Susquehanna International Group first reported a position in Cellectis in Q3 2016 and has held it in 25 quarters since.
  • Susquehanna International Group's Cellectis position peaked at $1.23M in Q4 2020.
  • 32 funds tracked by Wall St. Rank held Cellectis as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.